An NF-κB-specific inhibitor, IκBα, binds to and inhibits cyclin-dependent kinase 4

被引:29
作者
Li, JN [1 ]
Joo, SH
Tsai, MD
机构
[1] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA
关键词
D O I
10.1021/bi035390r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IkappaBalpha, a protein composed of six ankyrin repeats, is a specific inhibitor of nuclear factor kappaB (NF-kappaB) and functions in signal transductions in many different cell types. Using both in vivo yeast two-hybrid assays and in vitro activity and binding assays, we showed that IkappaBalpha binds to cyclin-dependent kinase 4 (CDK4) specifically and inhibits its kinase activity. The potencies of binding and inhibition of IkappaBalpha are comparable to those of INK4 proteins, the specific CDK4 inhibitors that also contain ankyrin repeats. Furthermore, we showed that INK4 proteins and IkappaBalpha compete with each other for binding to CDK4. These results led us to propose a hypothesis that there is cross talk between the NF-kappaB/IkappaBalpha-pathway and the p16/CDK4/Rb pathway in cells, and that IkappaBalpha could substitute for the CDK4-inhibiting function of p16, a tumor suppressor frequently inactivated in human tumors. To further understand the structural basis of IkappaBalpha-CDK binding, we used different mutants of CDK4 to show that there are notable differences between IkappaBalpha and INK4 proteins in CDK4 binding since the binding is affected differently by different CDK4 mutations. We also demonstrated that the interaction of IkappaBalpha with CDK4 is different from that with its NF-kappaB. While most of the contacts contributing to NF-kappaB binding are located within the last two C-terminal ankyrin repeats and the loop region bridging them, the first four ankyrin repeats at the N-terminus are responsible for CDK4 binding and inhibition.
引用
收藏
页码:13476 / 13483
页数:8
相关论文
共 34 条
[1]  
BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
[2]   Crystal structure of the complex of the cyclin D dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d [J].
Brotherton, DH ;
Dhanaraj, V ;
Wick, S ;
Brizuela, L ;
Domaille, PJ ;
Volyanik, E ;
Xu, X ;
Parisini, E ;
Smith, BO ;
Archer, SJ ;
Serrano, M ;
Brenner, SL ;
Blundell, TL ;
Laue, ED .
NATURE, 1998, 395 (6699) :244-250
[3]   Tumor suppressor p16INK4A:: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 [J].
Byeon, IJL ;
Li, JN ;
Ericson, K ;
Selby, TL ;
Tevelev, A ;
Kim, HJ ;
O'Maille, P ;
Tsai, MD .
MOLECULAR CELL, 1998, 1 (03) :421-431
[4]   Several noncontiguous domains of CDK4 are involved in binding to the p16 tumor suppressor protein [J].
Ceha, HM ;
Nasser, I ;
Medema, RH ;
Slebos, RJC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) :550-555
[5]   Identification of CDK4 sequences involved in cyclin D1 and p16 binding [J].
Coleman, KG ;
Wautlet, BS ;
Morrissey, D ;
Mulheron, J ;
Sedman, SA ;
Brinkley, P ;
Price, S ;
Webster, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18869-18874
[6]   MULTIPLE SEQUENCE ALIGNMENT WITH HIERARCHICAL-CLUSTERING [J].
CORPET, F .
NUCLEIC ACIDS RESEARCH, 1988, 16 (22) :10881-10890
[7]   Tyrosine phosphorylation of IκBα activates NFκB through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation [J].
Fan, CG ;
Li, Q ;
Ross, D ;
Engelhardt, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :2072-2080
[8]   Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo [J].
Ghaneh, P ;
Greenhalf, W ;
Humphreys, M ;
Wilson, D ;
Zumstein, L ;
Lemoine, NR ;
Neoptolemos, JP .
GENE THERAPY, 2001, 8 (03) :199-208
[9]   Phosphorylation of p16INK4A correlates with Cdk4 association [J].
Gump, J ;
Stokoe, D ;
McCormick, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :6619-6622
[10]   TAX PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I BINDS TO THE ANKYRIN MOTIFS OF INHIBITORY FACTOR KAPPA-B AND INDUCES NUCLEAR TRANSLOCATION OF TRANSCRIPTION FACTOR NF-KAPPA-B PROTEINS FOR TRANSCRIPTIONAL ACTIVATION [J].
HIRAI, H ;
SUZUKI, T ;
FUJISAWA, J ;
INOUE, J ;
YOSHIDA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3584-3588